Smith & Nephew PLC (NYSE:SNN)’s share price fell 5.5% during trading on Thursday . The company traded as low as $32.66 and last traded at $32.71, with a volume of 1,107,468 shares traded. The stock had previously closed at $34.60.

A number of brokerages recently commented on SNN. Zacks Investment Research downgraded Smith & Nephew PLC from a “hold” rating to a “sell” rating in a research report on Wednesday, July 6th. Morgan Stanley reiterated an “equal weight” rating on shares of Smith & Nephew PLC in a research report on Monday, April 11th. Finally, Jefferies Group upgraded Smith & Nephew PLC from a “hold” rating to a “buy” rating in a research report on Monday, May 9th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $37.00.

The company has a market capitalization of $14.88 billion and a PE ratio of 41.93. The company has a 50-day moving average of $33.84 and a 200-day moving average of $33.41.

A number of large investors recently made changes to their positions in SNN. Sei Investments Co. boosted its stake in shares of Smith & Nephew PLC by 2.1% in the fourth quarter. Sei Investments Co. now owns 39,456 shares of the company’s stock worth $1,405,000 after buying an additional 821 shares during the period. US Bancorp DE boosted its stake in shares of Smith & Nephew PLC by 37.6% in the fourth quarter. US Bancorp DE now owns 253,952 shares of the company’s stock worth $9,041,000 after buying an additional 69,437 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of Smith & Nephew PLC by 6.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 254,835 shares of the company’s stock worth $9,072,000 after buying an additional 15,270 shares during the period. Finally, Wells Fargo & Company MN raised its position in shares of Smith & Nephew PLC by 4.3% in the fourth quarter. Wells Fargo & Company MN now owns 380,789 shares of the company’s stock worth $13,556,000 after buying an additional 15,869 shares in the last quarter.

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.